William Muller

14PUBLICATIONS
61CO-AUTHORS
Cancer cell biologyPredictive and prognostic markersMolecular targetsCancer geneticsSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jan 28, 2026
EZH2 directs HER2+ breast cancer progression through the modulation of epithelial plasticity.

Linshan Liu, Ellie J Massey, Dongmei Zuo

|Aug 12, 2025
Increased ErbB2 Signaling Is an Early Adaptation to Androgen Signaling Inhibition and Persists in Castration-Resistant Prostate Cancer.

Jude Owiredu, Betul Ersoy-Fazlioglu, Larysa Poluben

|Oct 25, 2024
Osteopontin is a therapeutic target that drives breast cancer recurrence.

Yu Gu, Tarek Taifour, Tung Bui

Pageof 3